Product Information

SUBVENITE 100 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0468 per EA under NDC 69102031901. Its NADAC has been published 410 times since Aug 22, 2018.

The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SUBVENITE 100 MG TABLET

LAMOTRIGINE
$0.0468per EA
High Outlier

Strength

100 mg/1

NDC

69102031901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078947

On Market Since

3/10/2018

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for SUBVENITE 100 MG TABLET has been published 410 times since Aug 22, 2018, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0468 per EA
All-time high$0.0640 (Apr 13, 2022)
All-time low$0.0379 (Nov 20, 2024)
52-week high$0.0491
52-week low$0.0441
Median price$0.0506
Average price$0.0515
Largest weekly change-23.6% (Nov 20, 2024)
Weeks tracked410
Tracking sinceAug 22, 2018

Price History

1W

0.0%

1M

+2.8%

3M

+6.1%

6M

+2.2%

1Y

+0.3%

3Y

-14.8%

5Y

-23.0%

All

-6.5%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SUBVENITE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SUBVENITE 100 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0468 per EA (NDC 69102031901), effective Jun 24, 2026.

How has the price of SUBVENITE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for SUBVENITE 100 MG TABLET has declined 6.5%. It has been tracked across 410 weekly CMS publications since Aug 22, 2018.

What are the highest and lowest recorded NADAC prices for SUBVENITE 100 MG TABLET?

Since Aug 22, 2018, the NADAC for SUBVENITE 100 MG TABLET has ranged from a low of $0.0379 (Nov 20, 2024) to a high of $0.0640 (Apr 13, 2022), with a median of $0.0506 per EA.

Are there cheaper alternatives to SUBVENITE 100 MG TABLET?

2 NADAC-published products share the same active ingredient, strength, and dosage form as SUBVENITE 100 MG TABLET, but none are currently priced below it.

Who manufactures SUBVENITE 100 MG TABLET?

SUBVENITE 100 MG TABLET (NDC 69102031901) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.